Nazca lanza la venta de Nutris por 300 millones
La operación despierta un gran interés entre fondos internacionales de capital riesgo. Las ofertas no vinculantes se esperan en diciembre. Leer
Spanish private equity firm Nazca Capital is selling its majority stake in Nutris, a Spanish company specializing in the production of nutritionally enriched gummy supplements. The sale is attracting significant interest from international venture capital funds. Bids are expected in December, with the process coordinated by Houlihan Lokey.
Potential buyers include Keensight, PAI Partners, and TA Associates, among others such as Advent, Ardian, EQT, Fremman, and IK Partners. Nutris, founded in 2013 and headquartered in Madrid, has seen its revenues and EBITDA more than triple since Nazca acquired a majority stake in 2021. The company plans to generate around €80 million in revenue and approximately €20 million in EBITDA in 2026.
Nutris produces supplements for third-party brands and distributes ingredients and probiotics to nutraceutical companies and supplement manufacturers. The company is targeting financially-focused investors, as both Nazca and the founders, Pedro de la Fuente and Inés de Santos, plan to reinvest alongside the new owner. Nutris's value is estimated at €250-300 million, considering its size and niche in the nutraceutical sector.
Written by urgent.news from Expansion ES's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
